Dewey Steadman | executive |
James Edgemond | executive |
Martine Rothblatt | executive |
Michael Benkowitz | executive |
Terence Flynn | analyst |
Roanna Clarissa Ruiz | analyst |
Ashwani Verma | analyst |
Leigh Peterson | executive |
Joseph Thome | analyst |
Good morning, and welcome to the United Therapeutics Corporation First Quarter 2024 Earnings Webcast. My name is Danielle, and I will be your conference operator today. [Operator Instructions] Please note, this call is being recorded. [Operator Instructions]. I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Thank you, Danielle, and good morning.